For: | Crippa S, Partelli S, Belfiori G, Palucci M, Muffatti F, Adamenko O, Cardinali L, Doglioni C, Zamboni G, Falconi M. Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology. World J Gastroenterol 2016; 22(45): 9944-9953 [PMID: 28018101 DOI: 10.3748/wjg.v22.i45.9944] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i45/9944.htm |
Number | Citing Articles |
1 |
Andrea Lania, Francesco Ferraù, Manila Rubino, Roberta Modica, Annamaria Colao, Antongiulio Faggiano. Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.651438
|
2 |
Burcin Özdirik, Anna K. Stueven, Raphael Mohr, Lukas Geisler, Alexander Wree, Jana Knorr, Münevver Demir, Mihael Vucur, Sven H. Loosen, Fabian Benz, Markus Reiss, Bertram Wiedenmann, Frank Tacke, Henning Jann, Teresa Hellberg, Christoph Roderburg. Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study. Journal of Clinical Medicine 2020; 9(9): 2881 doi: 10.3390/jcm9092881
|
3 |
Newton A C S Wong, Sari Suortamo, Elinor George, Sophie Beavers. Paraduodenal/pancreatic Ewing sarcoma is very rare and therefore may be mistaken for neuroendocrine carcinoma. Journal of Clinical Pathology 2022; 75(1): 71 doi: 10.1136/jclinpath-2021-207452
|
4 |
Tomoaki Hamana, Shigeru Sakurai, Atsuko Hamada, Shinnichi Sakamoto, Hisako Furusho, Shigeaki Toratani. A case of primary neuroendocrine carcinoma of the mandibular gingiva treated using multimodal therapy. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 2023; 35(1): 60 doi: 10.1016/j.ajoms.2022.07.013
|
5 |
Lingaku Lee, Tetsuhide Ito, Robert T. Jensen. Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies. Expert Review of Anticancer Therapy 2018; 18(9): 837 doi: 10.1080/14737140.2018.1496822
|
6 |
Martine Bocchini, Fabio Nicolini, Stefano Severi, Alberto Bongiovanni, Toni Ibrahim, Giorgia Simonetti, Ilaria Grassi, Massimiliano Mazza. Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00831
|
7 |
Tiffany J. Sinclair, George A. Poultsides. Islet Tumors. Advances in Surgery 2020; 54: 69 doi: 10.1016/j.yasu.2020.04.004
|
8 |
C Ricci, S Partelli, L Landoni, M Rinzivillo, C Ingaldi, V Andreasi, C Nessi, F Muffatti, M Fontana, D Tamburrino, G Deiro, L Alberici, D Campana, F Panzuto, C Bassi, M Falconi, R Casadei. Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis. British Journal of Surgery 2021; 108(7): 811 doi: 10.1093/bjs/znaa141
|
9 |
Adele Busico, Patrick Maisonneuve, Natalie Prinzi, Sara Pusceddu, Giovanni Centonze, Giovanna Garzone, Alessio Pellegrinelli, Luca Giacomelli, Alessandro Mangogna, Cinzia Paolino, Antonino Belfiore, Ketevani Kankava, Federica Perrone, Elena Tamborini, Giancarlo Pruneri, Nicola Fazio, Massimo Milione. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin. Neuroendocrinology 2020; 110(7-8): 616 doi: 10.1159/000503722
|
10 |
Filippo Borri, Rita Bonfiglio, Martina Mandarano. Hepato-Pancreato-Biliary Malignancies. 2021; : 1 doi: 10.1007/978-3-030-37482-2_37-1
|
11 |
Giovanni Guarneri, Giulia Gasparini, Stefano Crippa, Valentina Andreasi, Massimo Falconi. Diagnostic strategy with a solid pancreatic mass. La Presse Médicale 2019; 48(3): e125 doi: 10.1016/j.lpm.2019.02.026
|
12 |
|
13 |
Filippo Borri, Rita Bonfiglio, Martina Mandarano. Hepato-Pancreato-Biliary Malignancies. 2022; : 639 doi: 10.1007/978-3-030-41683-6_37
|
14 |
Bozena Smolkova, Agapi Kataki, Julie Earl, Ignacio Ruz-Caracuel, Marina Cihova, Maria Urbanova, Verona Buocikova, Sandra Tamargo, Vita Rovite, Helvijs Niedra, Joerg Schrader, Yvonne Kohl. Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms. Critical Reviews in Oncology/Hematology 2022; 180: 103865 doi: 10.1016/j.critrevonc.2022.103865
|
15 |
I. Pergolini, S. Crippa, M. Pagnanelli, G. Belfiori, A. Pucci, S. Partelli, C. Rubini, P. Castelli, G. Zamboni, M. Falconi. Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma. BJS Open 2019; 3(5): 646 doi: 10.1002/bjs5.50175
|
16 |
Rihong Zhang, Yu Guo, Youliang Wang, Li Hu, Cheng Fang, Yujie Yang, Xianqi Yang, Luohai Chen, Jie Chen, Wei Wang, Xiaowei Sun. Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system. Cancer Medicine 2023; 12(6): 6623 doi: 10.1002/cam4.5437
|
17 |
Akriti Pokhrel, Richard Wu, Jen Chin Wang. Review of Merkel cell carcinoma with solitary pancreatic metastases mimicking primary neuroendocrine tumor of the pancreas. Clinical Journal of Gastroenterology 2023; 16(5): 641 doi: 10.1007/s12328-023-01821-x
|
18 |
Maria Chiara Zatelli, Elia Guadagno, Erika Messina, Fabio Lo Calzo, Antongiulio Faggiano, Annamaria Colao, _ _. Open issues on G3 neuroendocrine neoplasms: back to the future. Endocrine-Related Cancer 2018; 25(6): R375 doi: 10.1530/ERC-17-0507
|
19 |
Burcin Özdirik, Anna Stueven, Jana Knorr, Lukas Geisler, Raphael Mohr, Münevver Demir, Teresa Hellberg, Sven H. Loosen, Fabian Benz, Bertram Wiedenmann, Frank Tacke, Alexander Wree, Henning Jann, Christoph Roderburg. Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies. Journal of Clinical Medicine 2020; 9(6): 1647 doi: 10.3390/jcm9061647
|
20 |
Krystallenia I. Alexandraki, Aggeliki Karapanagioti, Ioannis Karoumpalis, Georgios Boutzios, Gregory A. Kaltsas. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/9856140
|
21 |
Giuseppe Pelosi, Fabrizio Bianchi, Elisa Dama, Jasna Metovic, Marco Barella, Angelica Sonzogni, Adriana Albini, Mauro Papotti, Yulan Gong, Namrata Vijayvergia. A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors. Endocrine Pathology 2021; 32(3): 396 doi: 10.1007/s12022-020-09659-6
|
22 |
Andrea Mafficini, Aldo Scarpa. Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms. Endocrine Reviews 2019; 40(2): 506 doi: 10.1210/er.2018-00160
|
23 |
Florian Primavesi, Eckhard Klieser, Benno Cardini, Katharina Marsoner, Uwe Fröschl, Sabine Thalhammer, Ines Fischer, Andreas Hauer, Romana Urbas, Tobias Kiesslich, Daniel Neureiter, Matthias Zitt, Reinhold Klug, Helwig Wundsam, Franz Sellner, Josef Karner, Reinhold Függer, Fergül Cakar-Beck, Peter Kornprat, Dietmar Öfner, Stefan Stättner. Exploring the surgical landscape of pancreatic neuroendocrine neoplasia in Austria: Results from the ASSO pNEN study group. European Journal of Surgical Oncology 2019; 45(2): 198 doi: 10.1016/j.ejso.2018.08.016
|
24 |
Amy Chang, Scott K. Sherman, James R. Howe, Vaibhav Sahai. Progress in the Management of Pancreatic Neuroendocrine Tumors. Annual Review of Medicine 2022; 73(1): 213 doi: 10.1146/annurev-med-042320-011248
|
25 |
Daniel M. Girardi, Andrea C.B. Silva, Juliana Florinda M. Rêgo, Renata A. Coudry, Rachel P. Riechelmann. Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: A systematic review. Cancer Treatment Reviews 2017; 56: 28 doi: 10.1016/j.ctrv.2017.04.002
|
26 |
Rui Mao, Kan Li, Jian-Qiang Cai, Sheng Luo, Megan Turner, Dan Blazer, Hong Zhao. Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas. Annals of Surgery 2021; 274(2): e126 doi: 10.1097/SLA.0000000000003562
|
27 |
Kevin Doello, Maria Angeles Chico, Francisco Quiñonero, Raúl Ortiz, Jose Prados, Cristina Mesas, Consolación Melguizo. Clinical Evaluation of Response to Octreotide and Chemotherapy in High-Grade Malignant Neuroendocrine Tumors and Promising In Vitro Preclinical Results with Pasireotide. Medicina 2024; 60(7): 1039 doi: 10.3390/medicina60071039
|
28 |
Christina Kanaan, Mohamed-Amine Bani, Michel Ducreux, David Planchard, Livia Lamartina, Sophie Moog, Thomas Pudlarz, Eric Baudin, Julien Hadoux, Abir Al-Ghuzlan, Jean-Yves Scoazec. Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms. Virchows Archiv 2024; doi: 10.1007/s00428-024-04006-0
|